Equities

hVIVO PLC

HVO:LSE

hVIVO PLC

Health CareHealth Care Providers
  • Price (GBX)6.10
  • Today's Change0.0000000000000009 / 0.00%
  • Shares traded1.49m
  • 1 Year change-67.03%
  • Beta2.0052
Data delayed at least 20 minutes, as of Feb 06 2026 16:24 GMT.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy2
Outperform3
Hold2
Sell0
Strong Sell0

Share price forecast

The 8 analysts offering 12 month price targets for hVIVO PLC have a median target of 16.75, with a high estimate of 29.00 and a low estimate of 10.00. The median estimate represents a 174.59% increase from the last price of 6.10.
High375.4%29.00
Med174.6%16.75
Low63.9%10.00

Dividends

In 2024, hVIVO PLC reported a dividend of 0.00 GBP, equaling last years dividend. The 7 analysts covering the company expect dividends of 0.00 GBP for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates

hVIVO PLC reported annual 2024 earnings of 1.67 per share on Apr 10, 2025.
Average growth rate+56.32%
More ▼

Revenue history & estimates

Open Orphan plc had revenues for the full year 2024 of 62.73m. This was 11.92% above the prior year's results.
Average growth rate+34.49%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.